Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (231-240 of 918) with videos related to

Pageof 92
Sort By:
European Urology|January 1, 2003
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tablesMarkus Graefen, Herbert Augustin, Pierre I Karakiewicz, et al.
The Journal of Urology|February 21, 2017
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® GuidelineRaisa S Pompe, Pierre I Karakiewicz, Zhe Tian, et al.
World Journal of Urology|June 26, 2015
Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control studyKatharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
BJU International|March 7, 2008
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive casesJochen Walz, Francesco Montorsi, Claudio Jeldres, et al.
BJU International|May 5, 2018
Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardised reporting systemsRaisa S Pompe, Burkhard Beyer, Alexander Haese, et al.
Urology|July 25, 2009
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysistUmberto Capitanio, Hendrik Isbarn, Shahrokh F Shariat, et al.
The Journal of Urology|December 16, 2014
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortDerya Tilki, Philipp Mandel, Thorsten Schlomm, et al.
International Journal of Cancer|August 14, 2012
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancersJulia Müller, Arne Ehlers, Lia Burkhardt, et al.
Clinical & Experimental Metastasis|January 30, 2025
Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care?Giovanni Mazzucato, Fabian Falkenbach, Jonas Ekrutt, et al.
The Prostate|October 9, 2024
Size and SUV<sub>max</sub> define the contribution of nodal metastases to PSA in oligorecurrent prostate cancerFabian Falkenbach, Marie-Lena Schmalhofer, Zhe Tian, et al.
Pageof 92

Showing results (231-240 of 918) with videos related to

Sort By:
Pageof 92
European Urology|January 1, 2003
Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tablesMarkus Graefen, Herbert Augustin, Pierre I Karakiewicz, et al.
The Journal of Urology|February 21, 2017
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® GuidelineRaisa S Pompe, Pierre I Karakiewicz, Zhe Tian, et al.
World Journal of Urology|June 26, 2015
Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control studyKatharina Boehm, Roger Valdivieso, Malek Meskawi, et al.
BJU International|March 7, 2008
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive casesJochen Walz, Francesco Montorsi, Claudio Jeldres, et al.
BJU International|May 5, 2018
Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardised reporting systemsRaisa S Pompe, Burkhard Beyer, Alexander Haese, et al.
Urology|July 25, 2009
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysistUmberto Capitanio, Hendrik Isbarn, Shahrokh F Shariat, et al.
The Journal of Urology|December 16, 2014
External validation of the CAPRA-S score to predict biochemical recurrence, metastasis and mortality after radical prostatectomy in a European cohortDerya Tilki, Philipp Mandel, Thorsten Schlomm, et al.
International Journal of Cancer|August 14, 2012
Loss of pSer2448-mTOR expression is linked to adverse prognosis and tumor progression in ERG-fusion-positive cancersJulia Müller, Arne Ehlers, Lia Burkhardt, et al.
Clinical & Experimental Metastasis|January 30, 2025
Incisional PSMA PET/CT-positive recurrences in prostate cancer- is there an implication on clinical care?Giovanni Mazzucato, Fabian Falkenbach, Jonas Ekrutt, et al.
The Prostate|October 9, 2024
Size and SUV<sub>max</sub> define the contribution of nodal metastases to PSA in oligorecurrent prostate cancerFabian Falkenbach, Marie-Lena Schmalhofer, Zhe Tian, et al.
Pageof 92